Top
image credit: Pixabay

New York Regulator Issues Insurance Fraud Action Against Two Opioid Manufacturers

August 20, 2020

The New York State Department of Financial Services (DFS) has filed charges and initiated administrative proceedings against Teva Pharmaceutical Industries Ltd. and its subsidiaries, as well as Allergan PLC and its subsidiary Allergan Finance LLC, in connection with the opioid crisis.

These charges are the third set to be filed in DFS’s ongoing investigation into the entities that created and perpetuated the opioid crisis.

Read More on Insurance Journal